Delta Air Lines Inc. Series 2001-1 Certificates Assigned Preliminary Ratings Sep 01

  • ID: 1929355
  • September 2001
  • Standard & Poors
1 of 3

NEW YORK (Standard & Poor's) Sept. 6, 2001 Standard & Poor's today assigned preliminary ratings to Delta Air Lines Inc.'s various classes of pass-through certificates series 2001-1 (see list below). Final ratings will be assigned upon completion of the review of legal documentation. The certificates are secured by equipment notes issued by Delta. The notes, in turn, are secured by 16 Boeing 737-832, 13 Boeing 757-232, and seven Boeing 767-332ER passenger jet aircraft delivered between March 1995 and June 2001. The preliminary ratings are based on: -- The corporate credit rating on Delta Air Lines Inc. (BBB-/Negative/--); -- The availability of special protections under Section 1110 of the U.S. Bankruptcy Code to owners of equipment notes (and thus, indirectly, to...

Companies mentioned in this report are:
- Delta Air Lines Inc.

Action: New Rating

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

Research type: News
This product is a is a brief one-page announcement of no more than 500 words with a quote from the analyst. It is media and investor focused with no accompanying commentary article.

Note: Product cover images may vary from those shown
2 of 3

- Delta Air Lines Inc.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown





Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.